Literature DB >> 11480221

Animal models of tardive dyskinesia--a review.

S K Kulkarni1, P S Naidu.   

Abstract

Tardive dyskinesia is a serious motor side effect of long term neuroleptic therapy, with an unknown pathophysiological basis. The leading hypothesis of the pathophysiology of tardive dyskinesia includes dopamine receptor supersensitivity, GABAergic hypofunction, excitotoxicity and oxidative stress. Many preclinical models have been developed to identify the underlying pathological processes of tardive dyskinesia, but none has yet produced a parsimonious results. A wide range of animal models, viz. Homologous, analogous and correlational models have been developed to explore the pathophysiology of tardive dyskinesia. Vacuous chewing movements in rodents induced by chronic neuroleptic treatment is the most frequently employed model. As the existing models suffer from several phenomenological and methodological problems, development of new models, highly predictive of pathological basis of tardive dyskinesia can accelerate tardive dyskinesia research for the better understanding of the pathophysiological processes underlying the syndrome and for the discovery of new therapeutic targets for the treatment of tardive dyskinesia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11480221

Source DB:  PubMed          Journal:  Indian J Physiol Pharmacol        ISSN: 0019-5499


  3 in total

1.  α-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt/GSK-3β signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia.

Authors:  Jessica Deslauriers; Christian Desmarais; Philippe Sarret; Sylvain Grignon
Journal:  J Mol Neurosci       Date:  2012-09-14       Impact factor: 3.444

Review 2.  Experimental treatment of antipsychotic-induced movement disorders.

Authors:  Erum Shireen
Journal:  J Exp Pharmacol       Date:  2016-08-08

3.  Levosulpiride-induced Movement Disorders.

Authors:  Supriyo Choudhury; Koustav Chatterjee; Ravi Singh; Shantanu Shubham; Santosh Trivedi; Suparna Chatterjee; Hrishikesh Kumar
Journal:  J Pharmacol Pharmacother       Date:  2017 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.